However, some studies indicated that PTPRM was negatively correlated with the progression of colorectal adenoma-carcinoma, small intestinal neuroendocrine tumors and breast cancer11–13. This evidence concerns the gene PTPRM and small intestine neuroendocrine neoplasm.